Category Archives: Avodart

Featured Stories

FDA Advisory Panel Wrestling with Metal-on-Metal Hip Replacement Safety

An advisory panel for the U.S. Food & Drug Administration (FDA) began a highly-anticipated meeting yesterday to discuss the safety of metal-on-metal hip implants. Among other things, the panel of outside experts is being asked to make recommendations regarding the best practices for monitoring patients with metal-on-metal hip replacements. ...

Read More

64 More Plavix Patients File Suit Over Bleeding Side Effects

Another Plavix lawsuit has been filed on behalf of 64 Plavix patients who allege bleeding side effects. Plavix (clopidogrel) is a blood thinner prescribed for the prevention of blood clots and heart attacks, and has been linked to serious side effects, such as the heart attacks and strokes it is ...

Read More

Johnson & Johnson Marketing of Gynecare Prolift Transvaginal Mesh Raises More Questions

Johnson & Johnson and its Ethicon unit are again coming under scrutiny for the way it marketed its Gynecare ProLift transvaginal mesh product. According to a new report from Bloomberg News, Johnson & Johnson continued marketing the Gynecare ProLift device for months after it received a warning from the ...

Read More

Transvaginal Mesh Lawsuit Trial

$5.5 Million Awarded to Plaintiffs in First Transvaginal Mesh Lawsuit Trial

An award of $5.5 million has been made in the first trial over a transvaginal mesh lawsuit. The jury found against medical device maker, C.R. Bard, and its Avaulta Plus transvaginal mesh. The jury agreed that Bard’s Avaulta Plus transvaginal mesh caused numerous and painful injuries in a California woman. ...

Read More

FDA Warning for Bone Graft Products in Patients Under 18

FDA Safety Warning for Bone Graft Products in Patients Under 18

FDA issued safety alerts to patients, parents & guardians, bone graft devices w/recombinant proteins or synthetic peptides not to be the first treatment for 18 & under.

Read More

Whistleblower Wins Retaliation - Canaveral National Seashore

Whistleblower Wins Retaliation Lawsuit

A whistleblower who reported misconduct at Canaveral National Seashore has won a retaliation ruling against the U.S. Department of Interior, Florida Today reports.

Read More

Smith & Nephew Says Metal-on-Metal Hip Replacement Controversy Slowing Sales of Birmingham Hip Resurfacing System

Medical device maker Smith & Nephew has reported a drop in sales of its metal-on-metal hip implant devices. According to the company, hip implant sales were down 2 percent during the first quarter of 2012, largely because its Birmingham Hip Resurfacing System suffered from an association with other metal-on-metal hip ...

Read More

First DePuy ASR Hip Implant Lawsuits Head to Trial in December, January

The first trials involving lawsuits filed against DePuy Orthopaedics by recipients of its recalled ASR Hip Implants will begin later this year, and early next year. The first is slated to start on December 3, 2012 in state court in Las Vegas, Nevada. A second DePuy ASR hip implant lawsuit ...

Read More

Canadian Study Finds Actos Raises Bladder Cancer Risk by 22 Percent

Yet another study is confirming the association between the diabetes drug, Actos, and bladder cancer. This latest research, published today in the Canadian Medical Association Journal, found that taking Actos raised the risk of bladder cancer among diabetics by about one-fifth.

Read More

Stryker Metal Hip Implant Component Recall Bad News for Makers of Metal-on-Metal Hip Replacement Devices

Stryker’s recent recall of two metal hip implant components, the Rejuvenate Modular and ABG II modular-neck hip stems, may have dealt a serious blow to one of the key arguments medical device manufacturers have made to defend their metal-on-metal hip replacements. Facing thousands of lawsuits, the makers of ...

Read More

Health Canada Issues Warning For Proscar, Propecia, Avodart, and Jalyn

Health Canada has issued a warning about Proscar, Propecia, Avodart, and Jalyn, medications prescribed for the treatment of enlarged prostate or mail-pattern baldness. The drugs may increase risks for a serious type of prostate cancer, said Health Canada, wrote the … Continue reading

Posted in Avodart, Jalyn, Pharmaceuticals, Propecia, Proscar |

Stay Away from Avodart, Public Citizen Warns

The consumer advocacy group, Public Citizen, has warned men to avoid taking < "http://www.yourlawyer.com/topics/overview/Avodart-Prostate-Cancer-Side-Effects-Lawsuit">Avodart (dutasteride), a drug used to treat enlarged prostate. According to the group, other treatments, including a class of drug known as alpha blockers, are often safer … Continue reading

Posted in Avodart, Jalyn, Pharmaceuticals, Propecia, Proscar |

Baldness, Prostate Drugs May Cause Persistent Erectile Dysfunction

Erectile dysfunction is a known side effect of < "http://www.yourlawyer.com/topics/overview/Propecia-Prostate-Cancer-Side-Effects-Lawsuit">Propecia, < "http://www.yourlawyer.com/topics/overview/Proscar-Prostate-Cancer-Side-Effects-Lawsuit">Proscar, < "http://www.yourlawyer.com/topics/overview/Avodart-Prostate-Cancer-Side-Effects-Lawsuit">Avodart or < "http://www.yourlawyer.com/topics/overview/Jalyn-Prostate-Cancer-Side-Effects-Lawsuit">Jalyn. But recent research out of Boston University indicates that in some cases, sexual dysfunction linked to these drugs could be irreversible, Propecia and … Continue reading

Posted in Avodart, Jalyn, Pharmaceuticals, Propecia, Proscar |

Proscar, Propecia Breast Cancer Reports Prompt Label Change in Canada

Health Canada announced yesterday that the manufacturers of finasteride products, including Propecia, < "http://www.yourlawyer.com/topics/overview/Proscar-Prostate-Cancer-Side-Effects-Lawsuit">Proscar and their generic equivalents, are updating the drugs’ labels to add safety information on rare reports of breast cancer in men. Patients taking Proscar, < "http://www.yourlawyer.com/topics/overview/Propecia-Prostate-Cancer-Side-Effects-Lawsuit">Propecia … Continue reading

Posted in Avodart, Jalyn, Pharmaceuticals, Propecia, Proscar |

FDA Warns Drugs for Enlarged Prostate, Hair Loss May Increase Risk of Aggressive Prostate Cancer

The U.S. Food & Drug Administration (FDA) announced yesterday that new warnings will be added to labels of < "http://www.yourlawyer.com/topics/overview/5-alpha-Reductase-Inhibitor-Proscar-Propecia-Avodart-Jalyn-Prostate-Cancer-Lawsuit">Proscar, Avodart, Jalyn and Propecia regarding a possible association with high-grade prostate cancer. Proscar, Avodart and Jalyn are all used to … Continue reading

Posted in Avodart, Jalyn, Legal News, Pharmaceuticals, Propecia, Proscar |

© 2005-2018 Parker Waichman LLP ®. All Rights Reserved.